2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z

Safety and Efficacy of Rabbit Anti-Thymocyte Globulin Induction in Pediatric Patients Undergoing Cardiac Transplantation

M. Sell,¹ A. Haney,¹ K. Sprott,¹ A. Burnette,² H. Henderson,² A. Savage.²
Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan

H. Harada,¹ Y. Watarai,² J. Uchida,³ O. Kamisawa.⁴
Safety and Efficacy of Sofosbuvir-Based Direct-Acting Antiviral Agents in Kidney Transplant Recipients with HCV: A Systematic Review and Meta-Analysis

X. Wang,¹ P. Tan,¹ T. Xiang,² Y. Qiu,¹ T. Song,¹ T. Lin.¹
Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients

D. Puliyanda, I. Kim, J. Choi, M. Haas, X. Zhang, A. Vo, H. Pizzo, S. Jordan.
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Safety of Antithymocyte Globulin Use in Donation after Circulatory Death (DCD) Liver Transplantation

D. Felix,¹ B. Geiger,¹ J. Descourouez,¹ M. Jorgenson,¹ B. Hanlon,² G. Leverson,² D. Foley.²
Scoring Transplant Glomerulopathy Using Morphometry: Correlation with Banff Criteria

M. Morales, A. Denic, W. Park, B. Smith, M. Alexander, M. Stegall.
Screening Coccidioides Serology in Kidney Transplant Recipients: A 10-Year Cross-Sectional Analysis

K. Phonphok,¹ T. Duong,¹ N. Datta,¹ O. Beaird,² J. Shaenman,² S. Bunnapradist.¹
Screening of RhoA/ROCK Inhibitors for the Ability to Prevent Chronic Rejection of Mouse Cardiac Allografts

W. Chen, W. Chen, X. Li, R. Ghobrial, M. Kloc.
Searching for Recipient-HLA Class II and Donor-HLA-Derived Peptide Complexes Inducing Protective Effect against De Novo Donor-Specific HLA Antibodies Formation in Kidney Transplantation

T. Tomosugi,¹ K. Iwasaki,¹ M. Okumura,¹ Y. Matsuoka,¹ K. Horimi,¹ M. Okada,² Y. Watarai,² T. Kobayashi.¹
Secular Trends in the Medical Complexity and Outcomes of Medicare-Insured Patients Undergoing Kidney Transplant

C. Lenihan,¹ S. Liu,¹ M. Montez-Rath,¹ W. Winkelmayer.²
Selection and Stratification of Anti-HLA-A and HLA-B Sensitized Patients in Pig-to-Human Xenotransplantation

G. Martens,¹ J. Ladowski,¹ J. Butler,² L. Reyes,¹ M. Tector,¹ A. Tector.¹
Self-Reported Post-Surgical Pain Following Living Kidney Donation

A. Fleishman,¹ J. Schold,² P. Morrissey,³ J. Whiting,⁴ J. Vella,⁴ L. Kayler,⁵ D. Katz,⁶ J. Jones,⁶ B. Kaplan,⁷ M. Pavlakis,¹ D. Mandelbrot,⁸ J. Rodrigue.¹
Senolytic Drug Treatment Attenuates mtDNA-Mediated Inflammatory Injury in Old Donors and Prolongs Cardiac Allograft Survival

K. Minami,¹ M. Seyda,¹ T. Heinbokel,¹ Y. Nian,¹ M. Quante,¹ G. Liu,¹ R. Abdi,² T. Tchkonia,³ J. Kirkland,³ A. Elkhal,¹ S. Tullius.¹
Sensing T Cell Killing Activity with Granzyme B Activity Probes

Q. Mac,¹ D. Mathews,² J. Kahla,¹ C. Stoffers,¹ O. Delmas,¹ B. Holt,¹ A. Adams,² G. Kwong.¹
Sequential Percutaneous Insertion of Two Plastic Biliary Stents through One Percutaneous Access for Biliary Anastomotic Strictures after Liver Transplantation

F. Boyvat,¹ A. Harman,¹ A. Akdur,² C. Aytekin,¹ M. Kirnap,² G. Moray,² M. Haberal.²
Serelaxin-Notch1 Signaling Promotes Macrophage M2 Differentiation and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation: From Mouse-to-Human

S. Kageyama,¹ K. Nakamura,¹ B. Ke,¹ R. Sosa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Serial Monitoring of Resolution of Sub-Clinical Acute Rejection (subAR) in Kidney Transplant Recipients (KTR) Using a Gene Expression Profile (GEP)

L. Zhao,¹ B. Armstrong,² J. Friedewald,¹ T. Whisenant,³ S. Kurian,³ R. Heilman,⁴ E. Poggio,⁵ C. Marsh,³ P. Baliga,⁶ N. Bridges,⁷ J. Odim,⁷ M. Brown,⁷ D. Ikle,² J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ M. Kandpal,¹ D. Salomon,³ M. Abecassis.¹
Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients

J. Mittal, J. Mogollon, K. Cowman, P. Nori, V. Muggia, G. Minamoto, Y. Puius.
Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation

A. L'Huillier,¹ V. Ferreira,¹ C. Hirzel,¹ E. Cordero,² A. Limaye,³ G. Reid,⁴ J. Englund,³ E. Blumberg,⁵ A. Humar,¹ D. Kumar.¹
Serum Treatment with Fetal Bovine Serum Significantly Increases Luminex-Based HLA Antibody Assay Specificity by Reducing Heterophile Antibody Interference

A. Jaramillo,¹ J. House,¹ L. Nelson,¹ S. Stoll,¹ R. Ridgley,¹ H. Khamash.²
SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes

M. Guthoff,¹ M. Mahling,¹ S. Nadalin,² N. Heyne.¹
Shared Genetic Ancestry as a Predictor of Medium Term Renal Transplant Outcome in Deceased Donor Transplants

C. Stapleton,¹ On behalf of the UK and Ireland Renal Transplant Consortium, P. Conlon,² G. Cavalleri.¹
Shared HLA Specificities between the Blood and Transplant Donor Increases the Risk of De Novo DSA Development Following Blood Transfusion in Transplant Recipients

S. Hassan,¹ F. Regan,² C. Brown,³ A. Harmer,² N. Anderson,² E. Santos,⁴ P. Brookes,⁴ D. Taube,¹ M. Willicombe.¹
Sharing Works; Avoiding Kidney Transplantation to an Unintended Recipient by Precision Virtual Cross Match with Excellent Outcomes

G. Roll,¹ A. Webber,¹ M. Travakol,¹ D. Gae,¹ L. Mayen,² V. Corpuz,¹ J. Roberts,¹ N. Ascher,¹ P. Stock,¹ R. Rajalingam.¹
Shikonin Inhibits Th17 Development through Repressing STAT3 Activation

H. Fang,¹ R. Zhang,¹ F. Liang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Short- and Long-Term Outcomes of Interventional Radiology Treatment for Vascular Complications Following Living Donor Liver Transplantation: The Efficacy of Stent Placement

S. Mizuno,¹ A. Nakatsuka,² A. Hayasaki,¹ U. Iizawa,¹ H. Kato,¹ Y. Murata,¹ A. Tanemura,¹ N. Kuriyama,¹ Y. Azumi,¹ M. Kishiwada,¹ M. Usui,¹ H. Sakurai,¹ H. Sakuma,² S. Isaji.¹
Short-Term Outcome Prediction Model in Deceased Donor Kidney Transplant Recipients

K. Archer,¹ Y. Zhang,¹ S. Bontha,² E. Akalin,³ L. Gallon,⁴ D. Maluf,² V. Mas.²
Shortened Cold Ischemia Time and Reduced Incidence of Delayed Graft Function for Kidney Transplants through Enhanced Tissue Compatibility Testing

I. Helanterä,¹ T. Saarinen,² J. Peräsaari,² M. Lempinen,¹ J. Lauronen.²
Shortening Length of Post-Operative In-Patient Stay for Living Kidney Donors

M. Loiselle, H. Bruschwein, J. Jacobs, S. Gulin, T. Rose, H. Arora, R. Nash, A. Toledo, T. Kozlowski.
Should Kidneys from Donation after Cardiac Death Expanded Criteria Donors Be Transplanted?

D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?

C. Hwang,¹ S. Levea,² M. MacConmara.¹
Side Effect Profile of Everolimus in Liver Transplant Patients

F. Kumssa, O. Sadiq, M. Alimirah, R. Kaur, A. Patel, S-.M. Jafri.
Significance of Antibody-Mediated Vascular Rejection (AMVR) on Graft Survival: Correlation with Pure Antibody-Mediated Rejection (AMR)

B. Ozdemir,¹ F. Ozdemir,² A. Terzi,² G. Ozdemir,¹ A. Ok Atilgan,¹ E. Ayvazoglu Soy,³ A. Akdur,³ G. Moray,³ M. Haberal.³
Significant Alteration in Transplant Center Performance Assessment with Extended Patient Follow Up Time

J. Schold, D. Goldfarb, S. Flechner, A. Wee, E. Poggio.
Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to a Standard Tacrolimus-MPA Regimen in De Novo Kidney Transplant Recipients: ATHENA 12 Months Data on Infections

A. Hauser,¹ C. Sommerer,¹ B. Suwelack,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² P. Schenker,¹ M. Junge,³ F. Thaiss,¹ B. Nashan.¹
Significant Difference between Proteasome and Immunoproteasome Inhibition in Acute Kidney Injury

F. Han, C. Ding, Y. Zhao, P. Tian.
Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients

S. Lee,¹ K. Huh,² J. Jeon,³ S-.J. Kim,⁴ Y. Kim,² C-.K. Oh.¹
Simultaneous Persistence and Development of Donor and Recipient Tissue Resident Memory T Cells in Lung Transplantation

M. Snyder,¹ T. Connors,² C. Marboe,³ L. Benvenuto,¹ L. Shah,¹ H. Robbins,¹ J. Hook,¹ F. D'Ovidio,⁴ M. Bacchetta,⁴ J. Sonnett,⁴ S. Arcasoy,¹ D. Farber.^4,5
Simultaneous versus Pretransplant Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease Patients

M. Eltemamy, A. Crane, M. Elmer-Dewitt, B. Frainey, A. Elshafei, A. Wee, D. Goldfarb, V. Krishnamurthi.
Single Center Experience in Use of Check Point Inhibitors and Outcomes in Kidney Transplant Recipients

K. Venkatachalam, R. Delos Santos, T. Alhamad.
Single Center Experience of HLA-Related Donor Specific Antibody in Living Donor Liver Transplantation

H. Egawa,¹ Y. Kotera,¹ A. Ohmori,¹ S. Yamashita,¹ T. Kato,¹ S. Nemoto,¹ T. Ishizuka,² M. Yamamoto.¹
Single Reduced Dose Thymoglobuline as Induction in Kidney Retransplant

K. Linhares-Silva, M. Cristelli, L. Viana, C. Felipe, H. Proença, R. de Marco, J. Medina-Pestana, H. Tedesco Silva J�nior.
Single versus Bilateral Simultaneous Nephrectomy during Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease

C. Choi,¹ S. Cho,¹ M-.J. Cho,¹ W. Cho,¹ S. Ahn,¹ S-.I. Min,¹ S-.K. Min,¹ S. Kim,² J. Ha.¹
Single vs. Multi-Drug Antibiotic Prophylaxis for Continuous-Flow Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis

S. Patel,¹ J. Choi,¹ E. Moncho Escrivà,² S. Rizvi,¹ L. Samuels,¹ J. Luc,³ R. Morris,¹ H. Massey,¹ V. Tchantchaleishvili,¹ N. Aburjania.⁴
Single-Cell Analysis of Graft Infiltrating T-Cells in Cardiac Allograft Vasculopathy

M. Habal, A. Myung, H. Yan, S. Rao, S. Lin, P. Colombo, C. Marboe, S. Restaino, A. Han, M. Farr, E. Zorn.
Single-Center Experience of Biliary Reconstruction for Multiple Bile Duct in Right Lobe Living Donor Liver Transplantation

J-.D. Kim, D-.L. Choi, T. Kim.
Single-Center Experience with Sofosbuvir-Based HCV Treatment after Kidney Transplantation

V. Garcia, G. Meinerz, C. da Silva, R. Bruno, E. Keitel.
Single-Dose Basiliximab Induction in Liver Transplant Recipients with Delayed CNI Initiation

D. Salerno,¹ N. Lange,¹ R. Rosenblatt,² C. Sammons,³ B. Fortune.²
Single-Dose Pharmacokinetics and Pharmacodynamics of Belatacept in Adolescent Kidney Transplant Recipients

A. Moudgil,¹ V. Dharnidharka,² D. Feig,³ B. Warshaw,⁴ V. Perera,⁵ B. Murthy,⁵ M. Roberts,⁵ M. Polinsky,⁵ R. Ettenger.⁶
Sirolimus Use Improves Cancer-Free Survival Following Transplantation: A Single Center 10-Year Analysis

P. Chen,² L. Nair,² A. Ata,² D. Conti,¹ R. Lopez-Soler.¹
Sirolimus-Based, Prednisone-Free Regimen in Kidney Transplantation: Long Term Results of an Open-Label, Randomized Controlled Trial

A. Shetty,¹ B. Ho,¹ V. Mas,² Y. Kassis,¹ S. Park,¹ J. Leventhal,¹ D. Chhabra,³ L. Gallon.¹
SIRT1-Ikaros Axis Promotes Macrophage M2 Polarization and Protects Liver Graft from Ischemia-Reperfusion Injury

K. Nakamura,¹ S. Kageyama,¹ X. Li,² A. Aziz,¹ R. Sosa,³ E. Reed,³ F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
Skeletons in the Closet? An Insight into Donor Liver Discards in the US

K. Halazun, A. Rana, G. Roll, P. Tabrizian, V. Agopian, B. Samstein, R. Brown, J. Emond.
Small-for-Size Grafts Increase Recurrence of Hepatocellular Carcinoma in Liver Transplantation beyond Milan Criteria

E. Lee, S. Kim, J. Shim, J. Park, B. Na, S-.J. Park.
Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients

N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.
Soluble Fibrinogen-Like Protein 2 Regulates Myeloid-Derived Suppressor Cells Differentiation and Enhances Its Immunosuppressive Function of in Allograft Immunity

C. Yang, T. Zhu.
South Asian and Muslim Canadian Patients Are Less Likely to Receive Living Donor Kidney Transplant Offers Compared to Caucasian, Non-Muslim Patients

A. Ali,¹ A. Ayub,¹ C. Richardson,¹ N. Edwards,¹ T. Ahmed,¹ M. Novak,^2,3 I. Mucsi.¹
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients

M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
Specific Monocyte Memory to Allogeneic MHC Mediated by Paired Immunoglobulin Receptors (PIR)

H. Dai,¹ P. Lan,² A. Friday,¹ A. Williams,¹ M. Oberbarnscheidt,¹ X. Li,² F. Lakkis.¹
Spigelius' Line Incision as a Successful Route to Extract the Kidney during Retroperitoneal Laparoscopic Live-Donor Nephrectomy

J. Qiu, G. Chen, Z. Wu, C. Wang, L. Chen.
Split/Reduced Liver Grafts in Adult Liver Transplantation, No Longer a Risk for Graft Loss

K. Sasaki, D. Firl, J. McVey, G. Iuppa, M. Fujiki, T. Diago Uso, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
Staged Biliary Reconstruction after Liver Transplantation Reduces Post-Transplant Biliary Complications in High-Acuity Patients

T. Pearson, M. Zimmerman, J. Kim, P. Palines, M. Wong, C. Erickson, J. Hong.
Standard Induction Immunosuppression Interferes with the Role of Vascularized Bone Marrow in Vascularized Composite Allograft Protection

N. Shockcor, E. Buckingham, W. Hassanein, A. Nam, S. Bartlett, R. Barth.
Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients

N. Wilson, N. Sulejmani, A. Jantz, A. Patel, B. Summers.
State of the Union: Outcomes of a Single Center's A₂-to-B Transplants Two Years after the Implementation of KAS

S. Radomski, S. Rosen-Bronson, D. Li, M. Awwad, G. Vranic, B. Javid, P. Abrams, S. Yi, M. Cooper, A. Gilbert.
Steroid Avoidance in Renal Transplant Patients Treated with Everolimus and Low-Exposure Tacrolimus

T. Sandes-Freitas,^1,2 M. Sales,¹ J. Oliveira,¹ M. Oliveira,¹ G. Dantas,² C. Girão,¹ R. Esmeraldo.¹
Steroid Sparing Maintenance Immunosuppression is Associated with Decreased Mortality after Simultaneous Liver Kidney Transplantation

S. Weeks, X. Luo, C. Song, L. Pote, A. Gurakar, F. Navqi, B. Philosophe, A. Cameron, N. Desai, S. Ottmann, D. Segev, J. Garonzik Wang.
Stress-Related Exosomal MicroRNA Biomarkers Released by Human Islets during Transplantation

P. Saravanan,¹ P. Nguyen,¹ G. Yoshimatsu,¹ C. Chang,¹ C. Darden,¹ R. Bhattacharjee,¹ X. Wang,¹ J. Gu,¹ M. Lawrence,¹ B. Naziruddin.²
Strongyloides Pre-Transplant Screening in Solid Organ Transplantation (SOT): Single Center Analysis

M. Al-Obaidi,¹ K. Vigil,¹ R. Hasbun,¹ A. De Golovine,² V. Machicao,³ L. Ostrosky,¹ S. Bynon,⁴ M. Nigo.¹
Sub-Clinical Acute Rejection (subAR) Detected by Both Surveillance Biopsy (SBx) and a Peripheral Blood Molecular Biomarker Correlates with De Novo Donor Specific Antibody (dnDSA) Following Kidney Transplant (KT)

R. Heilman,¹ J. Friedewald,² K. Kurian,⁵ T. Whisemant,⁵ E. Poggio,³ C. Marsh,⁵ P. Baliga,⁷ N. Bridges,⁴ J. Odim,⁴ M. Brown,⁴ D. Ikle,³ B. Armstrong,³ L. Zhao,² D. Salomon,⁵ M. Abecassis.²
Subclass Distribution of DSA Analyzed by Mass Spectrometry Predicts the Risk of Humoral Rejection

V. Pernin,^1,2 N. Bec,³ C. Larroque,³ C. Duperray,² G. Mourad,¹ M. Lequintrec.^1,2
Subclinical Borderline Rejection: More Than Meets the Eye?

M. Bernard, G. Agarwal, H. Fatima, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, A. Patel, G. Towns, M. Seifert, R. Mannon.
Subnormothermic Machine Perfusion (SNMP) with Human Hemoglobin(Hb)-Based Oxygen Carriers (HBOCs)perfusate Decreased Hepatocellular Reperfusion Injury of Donation after Cardiac Death (DCD) Donor in Pig Model

T. Shonaka,¹ N. Matsuno,¹ H. Obara,² R. Yoshikawa,² Y. Nishikawa,³ M. Gochi,¹ M. Otani,¹ H. Takahashi,¹ H. Azuma,³ H. Sakai,⁴ H. Furukawa.¹
Successful Desensitization with Carfilzomib-Based Regimen to Facilitate Lung Transplantation: Initial Experience

C. Ensor,¹ A. Zeevi,¹ M. Mangiola,¹ C. Iasella,¹ M. Marrari,¹ M. Morrell,¹ E. Lendermon,¹ S. Kilaru,¹ N. Shigemura,² J. DCunha,¹ J. McDyer.¹
Successful Management of Simultaneous Liver-Kidney Transplant Recipient with Primary Hyperoxaluria Using Intensive Continuous Dialysis

A. Abdelaziz, A. Nishio-Lucar, A. Doyle, S. Pelletier, S. Rasmussen, P. Lobo, K. Warburton.
Successful Patency in Blood Conduits for an Artificial Kidney Membrane with Biocompatible Coatings

R. Forbes,¹ E. Marsh,¹ S. Karp,¹ A. Buck,¹ D. Colvin,¹ P. Williams,¹ B. Chaudhuri,² S. Roy,² W. Fissell.¹
Successful Transplantation in a Sensitized Patient Allergic to Commercially Available Antibody Induction Agents

K. Venkatachalam, A. Malone.
Successful Transplantation of Black Kidneys from Rhabdomyolysis Donors

X-.P. Yuan,¹ C-.B. CHen,¹ Y. Zheng,¹ X. Gu,² Q. Zu,³ C. Wang,¹ X. He.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85 in Older Recipients

A. Nickkholgh,¹ A. Agarwal,¹ A. Nishio Lucar,² K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85: The Organ is Not Wholly to Blame

A. Agarwal,¹ A. Nishio Lucar,² A. Nickkholgh,¹ K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis

L. Coromina Hernandez, K. Sasaki, D. Firl, J. McVey, M. Fujiki, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
Supercooling of Human Livers to Extend the Preservation Time for Transplantation

R. de Vries,^1,2 S. Tessier,^1,2 P. Banik,^1,2 S. Ozer,^1,2 S. Napgal,^1,2 S. Cronin,^1,2 J. Markmann,^1,2 H. Yeh,^1,2 K. Uygun.^1,2
Superior Outcomes Using Normothermic Regional Perfusion in CDCD Liver Transplantation

A. Hessheimer, E. Coll, A. Valdivieso, M. Gómez, J. Santoyo, P. Ramírez, M. Gómez-Bravo, R. López-Andujar, J. Villar, C. Jiménez, F. Lluís, L. Lladó, D. Casanova, M. Barrera, R. Charco, J. López-Baena, J. Briceño, F. Pardo, G. Blanco, D. Pacheco, B. Domínguez-Gil, V. Sánchez-Turrión, C. Fondevila.
Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

M. J. Barten,¹ S. W. Hirt,¹ J. Garbade,¹ C. Bara,¹ A. Doesch,¹ C. Knosalla,¹ C. Grinninger,¹ J. Stypmann,¹ C. Sieder,² M. Junge,² U. Schulz.¹
Superiority of Early Everolimus-Based Quadruple Immunosuppression versus Standard Triple Therapy after Lung Transplantation: 12 Months Results from Prospective 4EVERLUNG Study in Germany

J. Gottlieb, C. Neurohr, J. Müller-Quernheim, H. Wirtz, B. Sill, H. Wilkens, V. Besa, C. Knosalla, M. Junge, C. Capusan, M. Strüber.
Surgical Categorization Improve Outcomes and Organ Utilization in Liver Transplant

H. Bohorquez,^1,2 H. Sharma,¹ D. Bruce,¹ A. Cohen,^1,2 C. Carmody,^1,2 J. Seal,¹ E. Bugeaud,¹ D. Sonnier,¹ A. Mathur,¹ D. Marroquin,¹ M. Voltz,¹ D. Lucia,¹ G. Loss.^1,2
Surgical Technique and Outcomes of Portal Vein Reconstruction of Adult-to-Adult Living Donor Liver Transplantation Recipients with Portal Vein Thrombosis

N. Kuriyama, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, A. Tanemura, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Surveillance for Mycoplasma/Ureaplasma Infection in Lung Transplant Recipients (LTRs)

L. Somerville, W. Sligl, N. Zelyas, D. Lien, J. Preiksaitis.
Survey of Rabbit Anti-Thymocyte Globulin Usage for Kidney Transplant Induction Therapy in the United States

K. Foster,¹ A. Dodson,² K. Gutierrez.²
Survival Advantage from Accepting a Circulatory Death Liver Transplant

J. Richards,¹ R. Taylor,² E. Allen,² A. Goh,¹ J. Neuberger,³ D. Collett,² G. Pettigrew.¹
Survival Benefit of Partial Grafts in Pediatric Candidates with Acute Liver Failure Awaiting Liver Transplantation: SRTR Analysis over 26 Years

D. Firl, K. Sasaki, C. Quintini, B. Eghtesad, C. Miller, K. Hashimoto.
Survival in Deceased Donor Kidney Transplant by Kidney Donor Profile Index versus Intensive Home Hemodialysis

A. Nishio-Lucar,¹ G. Lyons,² S. Bose,³ J. Ma,² K. Awuah,³ R. Lockridge.³
Survival Rates of Patients with Previous Cardiac Surgery Undergoing Lung Transplant

H. Niikawa, T. Okamoto, K. Ayyat, Y. Itoda, K. McCurry.
Survival, Cancer and PTLD Diagnosis after Late EBV Infection in Adult Kidney Transplantation

M. Morton,¹ G. Scullin,² K. Daga,² P. Klapper,² P. Vallely,² M. Picton.¹
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life

S. Elwir,¹ A. Warren,¹ G. Saracino,¹ S. Asrani,¹ T. Elliott,² G. Klintmalm.¹

Jump to: View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z